title: Fluorescent in situ hybridization as a primary test for HER2 status in breast cancer: controversies.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Arena
authors.forename: Ilaria
authors.initials: I
authors.lastname: Pennacchia
authors.forename: Giovanni
authors.initials: G
authors.lastname: Monego
authors.forename: Arnaldo
authors.initials: A
authors.lastname: Carbone
authors.forename: Arnaldo
authors.initials: A
authors.lastname: Capelli
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics*; D001943:Breast Neoplasms / Q000737:chemistry / Q000235:genetics*; D005260:Female; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis / Q000235:genetics*; D015203:Reproducibility of Results; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human